지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Age-related eyelid changes
대한미용의학회지
2017 .06
Eyelid Tumors: Clinical Data from an Eye Center in Ankara, Turkey
Asian Pacific journal of cancer prevention : APJCP
2015 .01
대표적인 눈꺼풀질환의 종류와 치료
대한의사협회지
2017 .01
Asian upper blepharoplasty
대한미용의학회지
2017 .01
Eyelid Schwannoma Mimicking Eyelid Amelanotic Nevus
Korean Journal of Ophthalmology
2019 .01
Comments on “Usefulness of the eyeball exposure area as an eye measurement modality through a comparison between eyes with inborn double eyelids and operated double eyelids”
Archives of Aesthetic Plastic Surgery
2022 .07
Radiation Therapy for Primary Eyelid Cancers in Tunisia
Asian Pacific journal of cancer prevention : APJCP
2016 .01
Preseptal upper eyelid lipoma: a case report
Archives of Aesthetic Plastic Surgery
2023 .04
성형 수술 후 부종에서 琥珀湯의 효과 : 2 증례보고
한방안이비인후피부과학회지
2020 .01
Sub-brow blepharoplasty for simultaneous correction of dermatochalasis with upper eyelid hooding and sunken eyelids
Archives of Aesthetic Plastic Surgery
2019 .01
뇌부종과 두개내압 상승의 기본치료원칙
대한의사협회지
2023 .05
New anthropometric data for preoperative planning in orbital wall fracture treatment: the use of eyelid drooping
Archives of craniofacial surgery : ACFS
2018 .01
Negative pressure pulmonary edema
Korean Journal of Anesthesiology
2018 .01
Treatment for ophthalmic paralysis: functional and aesthetic optimization
Archives of craniofacial surgery : ACFS
2019 .01
Verrucous Carcinoma of the Eyelid
Korean Journal of Ophthalmology
2016 .01
Distribution and Characteristics of Meibomian Gland Dysfunction Subtypes: A Multicenter Study in South Korea
Korean Journal of Ophthalmology
2019 .01
눈꺼풀로 전이된 진행성 위암
영남의대학술지
2016 .01
Correction of Cicatricial Upper Eyelid Ectropion Using a Dermofat Graft and an Anti-Adhesive Agent
Archives of Aesthetic Plastic Surgery
2018 .01
Tick Infestation of the Upper Eyelid
Korean Journal of Ophthalmology
2020 .01
0